1. Home
  2. EPRX
  3. EPRX News

Latest EUPRAXIA PHARMACEUTICALS INC (EPRX) News on May 30, 2024

Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

CNW Group

6 days ago

Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Share on Social Networks: